With limited evidence-based treatments and a pathophysiology still being pieced together, theres growing interest in repurposing medications used in other chronic or metabolic conditions
Available from: www.training.cochrane.org/handbook Bliddal H, Bays H, Czernichow S, et al
Key takeaways Some UnitedHealthcare plans cover Rybelsus, but coverage varies by insurance plan
PlexusDx supports precision wellness by helping patients and providers understand individual metabolic factors, genetic predispositions in peptide pathways, and how these may inform a more personalized treatment approach with qualified medical guidance
Mean difference in pain reduction as measured on a 10-cm VAS, and 95% CIs were used for pooling continuous data from each trial
315 However, CP31398 has not undergone clinical development